De novo proliferative glomerulonephritis with monoclonal IgG deposits in an adolescent kidney transplant recipient
Related Experiment Video
Updated: May 4, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Clarkson Crane1, Haiyan Zhang2, Elizabeth Ingulli3
1Department of Pediatrics, University of California, San Diego, 3020 Children's Way MC 5173, San Diego, CA, 92123, USA. crcrane@health.ucsd.edu.
Abstract:
Proliferative Glomerulonephritis with Monoclonal IgG Deposits (PGNMID) is a glomerular disease characterized by membranoproliferative and mesangioproliferative lesions, with granular capillary wall monoclonal IgG positivity and immunoglobulin light chain restriction. Most commonly a disease of older adults, we present the case of an 18-year-old patient who developed de novo PGNMID in a kidney allograft three years after kidney transplantation. There was minimal proteinuria and no serum paraproteinemia was detected, so the patient was managed conservatively. To our knowledge, this is the youngest reported case of de novo PGNMID occurring in a kidney allograft and highlights the importance of considering PGNMID as a possible etiology of de novo glomerular disease in adolescent and young adult patients.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention

